Russell J. Rigby

845 total citations
17 papers, 620 citations indexed

About

Russell J. Rigby is a scholar working on Nephrology, Surgery and Transplantation. According to data from OpenAlex, Russell J. Rigby has authored 17 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 5 papers in Surgery and 5 papers in Transplantation. Recurrent topics in Russell J. Rigby's work include Dialysis and Renal Disease Management (7 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Bone health and treatments (2 papers). Russell J. Rigby is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Bone health and treatments (2 papers). Russell J. Rigby collaborates with scholars based in Australia, United Kingdom and France. Russell J. Rigby's co-authors include Carmel M. Hawley, David W. Johnson, David M. Purdie, David L. Nicol, Karen A. Herzig, Allison Brown, David Saltissi, Justin Westhuyzen, Scott B. Campbell and Wendy Chang and has published in prestigious journals such as The American Journal of Medicine, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

Russell J. Rigby

15 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell J. Rigby Australia 12 288 265 218 106 101 17 620
Kirsten A. Armstrong Australia 13 252 0.9× 202 0.8× 230 1.1× 68 0.6× 98 1.0× 18 649
Altair Jacob Mocelin Brazil 9 133 0.5× 130 0.5× 79 0.4× 83 0.8× 77 0.8× 33 454
W. Geerlings Germany 15 340 1.2× 132 0.5× 87 0.4× 195 1.8× 155 1.5× 29 785
Ramesh Naik United Kingdom 13 271 0.9× 164 0.6× 50 0.2× 31 0.3× 111 1.1× 29 538
Luis F. Gimenez United States 12 539 1.9× 100 0.4× 96 0.4× 62 0.6× 112 1.1× 25 830
Theodore J. Buselmeier United States 14 163 0.6× 202 0.8× 166 0.8× 129 1.2× 114 1.1× 22 577
Mariken Gruppen Netherlands 8 410 1.4× 106 0.4× 77 0.4× 61 0.6× 100 1.0× 17 664
Sendogan Aker Germany 11 226 0.8× 122 0.5× 128 0.6× 34 0.3× 121 1.2× 17 496
Muralidhar Acharya United States 5 434 1.5× 87 0.3× 58 0.3× 37 0.3× 90 0.9× 6 687
Maurice Laville France 9 430 1.5× 117 0.4× 63 0.3× 74 0.7× 63 0.6× 13 683

Countries citing papers authored by Russell J. Rigby

Since Specialization
Citations

This map shows the geographic impact of Russell J. Rigby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell J. Rigby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell J. Rigby more than expected).

Fields of papers citing papers by Russell J. Rigby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell J. Rigby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell J. Rigby. The network helps show where Russell J. Rigby may publish in the future.

Co-authorship network of co-authors of Russell J. Rigby

This figure shows the co-authorship network connecting the top 25 collaborators of Russell J. Rigby. A scholar is included among the top collaborators of Russell J. Rigby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell J. Rigby. Russell J. Rigby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Saltissi, David, et al.. (2002). Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis. American Journal of Kidney Diseases. 39(2). 283–290. 64 indexed citations
2.
Pillans, Peter I., Russell J. Rigby, Paul Kubler, et al.. (2001). A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients. Clinical Biochemistry. 34(1). 77–81. 65 indexed citations
3.
Saltissi, David, et al.. (2001). Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis and hemodialysis patients. American Journal of Kidney Diseases. 37(6). 1209–1215. 17 indexed citations
4.
Johnson, David W., Karen A. Herzig, David M. Purdie, et al.. (2000). A COMPARISON OF THE EFFECTS OF DIALYSIS AND RENAL TRANSPLANTATION ON THE SURVIVAL OF OLDER UREMIC PATIENTS. Transplantation. 69(5). 794–799. 132 indexed citations
5.
Johnson, David W., Karen A. Herzig, David M. Purdie, et al.. (2000). Is Obesity a Favorable Prognostic Factor in Peritoneal Dialysis Patients?. Peritoneal Dialysis International. 20(6). 715–721. 99 indexed citations
6.
Rigby, Russell J., et al.. (1999). A double‐blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients. Clinical Transplantation. 13(6). 520–525. 20 indexed citations
7.
Hills, B. A., et al.. (1998). Proteolipid in Peritoneal Effluent of Capd Patients. Peritoneal Dialysis International. 18(2). 225–227. 2 indexed citations
8.
Johnson, David W., D. Carey, Mark S. Hibbins, et al.. (1998). Serum Leptin Correlates with Fat Mass but not Dietary Energy Intake in Continuous Ambulatory Peritoneal Dialysis Patients. Peritoneal Dialysis International. 18(6). 569–575. 12 indexed citations
9.
Johnson, David W., et al.. (1996). The Role of Dexa Bone Densitometry in Evaluating Renal Osteodystrophy in Continuous Ambulatory Peritoneal Dialysis Patients. Peritoneal Dialysis International. 16(1). 34–40. 25 indexed citations
10.
Hawley, Carmel M., Daryl R. Wall, David W. Johnson, et al.. (1995). Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. American Journal of Kidney Diseases. 26(4). 658–661. 38 indexed citations
11.
McIntyre, David, et al.. (1995). Long‐term bone loss after renal transplantation: comparison of immunosuppressive regimens. Clinical Transplantation. 9(1). 20–24. 53 indexed citations
12.
Mattern, William D., et al.. (1989). Selection of ESRD Treatment: An International Study. American Journal of Kidney Diseases. 13(6). 457–464. 30 indexed citations
13.
Petrie, James J. B., et al.. (1989). Effect of immunosuppression regimen and in vitro lymphokines on natural killer activity in renal transplantation. Clinical Transplantation. 3(5). 273–278.
14.
Steadman, Charles, et al.. (1987). Painful bone end sclerosis. The American Journal of Medicine. 82(1). 171–174.
15.
Rigby, Russell J., Ian R. Hardie, Darryl Wall, et al.. (1986). Abdominal Hernias Complicating Continuous Ambulatory Peritoneal Dialysis. American Journal of Nephrology. 6(4). 271–274. 44 indexed citations
16.
Rigby, Russell J., et al.. (1982). Experience with continuous ambulatory peritoneal dialysis. The Medical Journal of Australia. 1(8). 331–335. 8 indexed citations
17.
Rigby, Russell J., et al.. (1978). THE TREATMENT OF PARACETAMOL OVERDOSE WITH CHARCOAL HAEMOPERFUSION AND CYSTEAMINE. The Medical Journal of Australia. 1(7). 396–399. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026